Natarajan Sethuraman
Directeur Technique/Scientifique/R&D chez ENTRADA THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Natarajan Sethuraman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2017 | - |
Historique de carrière de Natarajan Sethuraman
Anciens postes connus de Natarajan Sethuraman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MERCK & CO., INC. | Directeur/Membre du Conseil | 01/08/2006 | 01/07/2016 |
| Corporate Officer/Principal | 01/08/2006 | 01/07/2016 | |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - | - |
Formation de Natarajan Sethuraman
| Tamilnadu Agricultural University | Undergraduate Degree |
| Indian Agricultural Research Institute | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Inde | 3 |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Bourse
- Insiders
- Natarajan Sethuraman
- Expérience